Myeloperoxidase (MPO), a heme enzyme secreted by activated phagocytes, gene
rates an array of oxidants proposed to play critical roles in host defense
and local tissue damage, Both MPO and its reaction products are present in
human atherosclerotic plaque, and it has been proposed that MPO oxidatively
modifies targets in the artery wall. We have now generated MPO-deficient m
ice, and show here that neutrophils from homozygous mutants lack peroxidase
and chlorination activity in vitro and fail to generate chlorotyrosine or
to kill Candida albicans in vivo. To examine the potential role of MPO in a
therosclerosis, we subjected LDL receptor-deficient mice to lethal irradiat
ion, repopulated their marrow with MPO-deficient or wild-type cells, and pr
ovided them a high-fat, high-cholesterol diet for 14 weeks. White cell coun
ts and plasma lipoprotein profiles were similar between the two groups at s
acrifice, Cross-sectional analysis of the aorta indicated that lesions in M
PO-deficient mice were about 50% larger than controls, Similar results were
obtained in a genetic cross with LDL receptor-deficient mice. In contrast
to advanced human atherosclerotic lesions, the chlorotyrosine content of ao
rtic lesions from wild-type as well as MPO-deficient mice was essentially u
ndetectable, These data suggest an unexpected, protective role for MPO-gene
rated reactive intermediates in murine atherosclerosis, They also identify
an important distinction between murine and human atherosclerosis with rega
rd to the potential involvement of MPO in protein oxidation.